{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:48:59Z","timestamp":1774936139581,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells with immunosuppressive functions. While early expansion of MDSCs may be protective in various pathological states, their accumulation and role might differ in sepsis. This study aimed to compare the differences in circulating myeloid cells with MDSC phenotypes and their subsets between septic and non-septic patients in the early stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a prospective, single-center, observational cohort study. Critically ill patients were enrolled and divided into sepsis and non-sepsis groups. Flow cytometry was used to determine the percentages of peripheral blood CD11b\n                      <jats:sup>+<\/jats:sup>\n                      CD33\n                      <jats:sup>+<\/jats:sup>\n                      HLA-DR\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/low cells (herein referred to as MDSC-like cells) and their subsets (M-MDSC-like and PMN-MDSC-like cells). Levels of arginase-1 (ARG-1) and inducible nitric oxide synthase (iNOS) were measured. Clinical data were collected. All patients were followed for 28 days to record mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty patients were enrolled (sepsis group: n=38; non-sepsis group: n=22). No significant differences were found in gender, age, APACHE II score, ICU length of stay, or 28-day mortality between the two groups. However, the Charlson Comorbidity Index (CCI) was higher in the sepsis group (P = 0.005). Compared to the non-sepsis group, septic patients had significantly lower percentages of total MDSC-like cells and M-MDSC-like cells (P = 0.006; P = 0.003), while PMN-MDSC-like cells showed no difference. ARG-1 levels were higher in the sepsis group (P = 0.030). Furthermore, the sepsis group exhibited significantly elevated levels of IL-6, CRP, PCT, and SOFA scores (P&amp;lt;0.05), lower lymphocyte counts (P = 0.017), and more pronounced coagulation abnormalities, hypoalbuminemia, and increased cardiac\/renal markers. Within the sepsis group, non-survivors had a significantly higher percentage of PMN-MDSC-like cells than survivors (P = 0.012).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the early stage, septic patients exhibit a distinct response profile of myeloid cells with MDSC phenotypes compared to non-septic patients, characterized by attenuated expansion of total MDSC-like cells and M-MDSC-like cells but enhanced ARG-1 expression, alongside more severe inflammation, organ dysfunction, and lymphopenia. An elevated percentage of PMN-MDSC-like cells is associated with poor prognosis in sepsis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1763005","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:11:56Z","timestamp":1774930316000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Levels of myeloid-derived suppressor cell-like cells in early sepsis: a comparative study with non-septic patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Lijing","family":"Jia","sequence":"first","affiliation":[{"name":"Hebei Medical University","place":["Shijiazhuang, China"]},{"name":"High Dependency Unit, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huawei","family":"Wang","sequence":"additional","affiliation":[{"name":"Hebei Medical University","place":["Shijiazhuang, China"]},{"name":"Department of Intensive Care Medicine, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Long","sequence":"additional","affiliation":[{"name":"Hebei Medical University","place":["Shijiazhuang, China"]},{"name":"Department of Intensive Care Medicine, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Ge","sequence":"additional","affiliation":[{"name":"Hebei Medical University","place":["Shijiazhuang, China"]},{"name":"Department of Intensive Care Medicine, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hebei Medical University","place":["Shijiazhuang, China"]},{"name":"Department of Intensive Care Medicine, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[{"name":"High Dependency Unit, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"High Dependency Unit, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heling","family":"Zhao","sequence":"additional","affiliation":[{"name":"Hebei Medical University","place":["Shijiazhuang, China"]},{"name":"Department of Intensive Care Medicine, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer","volume":"166","author":"lmand","year":"2001","journal-title":"J Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12461","article-title":"Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4+ Foxp3+ Treg expansion","volume":"13","author":"Luan","year":"2013","journal-title":"Am J Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaf8943","article-title":"Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients","volume":"1","author":"Condamine","year":"2016","journal-title":"Sci Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112949","article-title":"Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives","volume":"142","author":"Rajkumari","year":"2024","journal-title":"Int IMMUNOPHARMACOL"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00178","article-title":"A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma","volume":"17","author":"Cuenca","year":"2011","journal-title":"Mol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2019.03.001","article-title":"Burn injury is associated with an infiltration of the wound site with myeloid-derived suppressor cells","volume":"338","author":"Schwacha","year":"2019","journal-title":"Cell Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1158\/0008-5472.CAN-07-0211","article-title":"Re: the terminology issue for myeloid-derived suppressor cells","volume":"67","author":"Krystal","year":"2007","journal-title":"Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13054-020-02857-y","article-title":"Delayed persistence of elevated monocytic MDSC associates with deleterious outcomes in septic shock: a retrospective cohort study","volume":"24","author":"Waeckel","year":"2020","journal-title":"Crit Care"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01401","article-title":"Circulating myeloid derived suppressor cells (MDSC) that accumulate in premalignancy share phenotypic and functional characteristics with MDSC in cancer","volume":"10","author":"Ma","year":"2019","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00109","article-title":"The generation and identity of human myeloid-derived suppressor cells","volume":"10","author":"Bergenfelz","year":"2020","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S517333","article-title":"Early elevation of monocytic-to-polymorphonuclear myeloid-derived suppressor cells ratio in critical illness is associated with favorable clinical outcomes","volume":"18","author":"Jia","year":"2025","journal-title":"J Inflammation Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/jof5020037","article-title":"Candida\/Staphylococcal polymicrobial intra-abdominal infection: pathogenesis and perspectives for a novel form of trained innate immunity","volume":"5","author":"Esher","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00327","article-title":"Myeloid-derived suppressor cells in sepsis","volume":"10","author":"Schrijver","year":"2019","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.92267","article-title":"Malat1 regulates PMN-MDSC expansion and immunosuppression through p-STAT3 ubiquitination in sepsis","volume":"20","author":"Wang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B18","article-title":"Long non-coding RNA hotairm1 promotes S100A9 support of MDSC expansion during sepsis","volume":"11","author":"Alkhateeb","year":"2020","journal-title":"J Clin Cell Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7990","DOI":"10.7150\/thno.112339","article-title":"Pharmacological and genetic inhibition of ARG2 in CXCR2Hi myeloid-derived suppressor cells combats sepsis-induced lymphopenia","volume":"15","author":"Long","year":"2025","journal-title":"Theranostics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.64898\/2025.12.16.694726","article-title":"Prolonged loss of oxidative phosphorylation and mitochondrial mass characterize CD66b + Leukocytes from patients with sepsis","volume":"18","author":"Rodhouse","year":"2025","journal-title":"bioRxiv"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092139","article-title":"Immunodynamic disruption in sepsis: mechanisms and strategies for personalized immunomodulation","volume":"13","author":"Saavedra-Torres","year":"2025","journal-title":"Biomedicines"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e42517","DOI":"10.7759\/cureus.42517","article-title":"Bone marrow changes in septic shock: A comprehensive review","volume":"15","author":"Nagaraju","year":"2023","journal-title":"Cureus"},{"key":"B23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13613-021-00893-7","article-title":"Energetic dysfunction in sepsis: a narrative review","volume":"11","author":"Preau","year":"2021","journal-title":"Ann Intensive Care"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000506","article-title":"Danger in the intensive care unit: damps in critically ill patients","volume":"45","author":"Timmermans","year":"2016","journal-title":"Shock"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2012.1014","article-title":"Endogenous glucocorticoids promote the expansion of myeloid-derived suppressor cells in a murine model of trauma","volume":"30","author":"Zhang","year":"2012","journal-title":"Int J Mol Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3MA0821-029R","article-title":"Polymorphonuclear myeloid-derived suppressor cells link inflammation and damage response after trauma","volume":"110","author":"Li","year":"2021","journal-title":"J LEUKOCYTE Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2019.03.015","article-title":"Myeloid-derived suppressor cells infiltrate the brain and suppress neuroinflammation in a mouse model of focal traumatic brain injury","volume":"406","author":"Hosomi","year":"2019","journal-title":"Neuroscience"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7150\/thno.119474","article-title":"Nociceptive neurons promote myeloid-derived suppressor cell mobilization to alleviate post-stroke neuroinflammation","volume":"15","author":"Cai","year":"2025","journal-title":"Theranostics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840620","article-title":"Myeloid-derived suppressor cells in patients with acute pancreatitis with increased inhibitory function","volume":"13","author":"Ding","year":"2022","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ni1001-907","article-title":"Nitric oxide and the immune response","volume":"2","author":"Bogdan","year":"2001","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives","volume":"222","author":"Rodr\u00edguez","year":"2008","journal-title":"Immunol Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001795","article-title":"Myeloid-derived suppressor cells (MDSCs) and the immunoinflammatory response to injury (Mini review)","volume":"56","author":"Sayyadioskoie","year":"2021","journal-title":"SHOCK"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201606-1143OC","article-title":"Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis","volume":"196","author":"Uhel","year":"2017","journal-title":"Am J Resp Crit Care"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12289","article-title":"LDK378 inhibits the recruitment of myeloid-derived suppressor cells to spleen via the p38-GRK2-CCR2 pathway in mice with sepsis","volume":"97","author":"Hu","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2022.06.038","article-title":"IL-1R1 blockade attenuates liver injury through inhibiting the recruitment of myeloid-derived suppressor cells in sepsis","volume":"620","author":"Luo","year":"2022","journal-title":"Biochem BIOPH Res CO"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5847\/wjem.j.1920-8642.2022.068","article-title":"Neutrophils inhibit CD8+ T cells immune response by arginase-1 signaling in patients with sepsis","volume":"13","author":"Dai","year":"2022","journal-title":"World J Emerg Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/circ.116.suppl_16.ii_29-c","article-title":"Abstract 250: over-expression of human arginase (ARG1) in macrophages reduces atherosclerosis in LDL-receptor deficient mice","volume":"116","author":"Teupser","year":"2007","journal-title":"CIRCULATION"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104302","article-title":"Myeloid-derived suppressor cells (MDSC): When good intentions go awry","volume":"362","author":"Sanchez-Pino","year":"2021","journal-title":"Cell Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820139.2025.2583275","article-title":"The role of myeloid-derived suppressor cell (MDSC) in fungal infections and its potential as a therapeutic target","volume":"11","author":"Mahdi","year":"2025","journal-title":"Immunol Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2127455","article-title":"Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomyelitis","volume":"14","author":"Radojevi\u0107","year":"2022","journal-title":"GUT Microbes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106208","article-title":"Glycolysis inhibition ameliorates brain injury after ischemic stroke by promoting the function of myeloid-derived suppressor cells","volume":"179","author":"Yan","year":"2022","journal-title":"Pharmacol Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e924724","DOI":"10.12659\/MSM.924724","article-title":"Protective effect of curcumin on bone trauma in a rat model via expansion of myeloid derived suppressor cells","volume":"26","author":"Zhang","year":"2020","journal-title":"Med Sci Monit"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104363","article-title":"Immunopathophysiology of human sepsis","volume":"86","author":"Wiersinga","year":"2022","journal-title":"EBioMedicine"},{"key":"B44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s13054-019-2628-x","article-title":"Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis","volume":"23","author":"Hollen","year":"2019","journal-title":"Crit Care"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1415274","article-title":"From immune dysregulation to organ dysfunction: understanding the enigma of Sepsis","volume":"15","author":"Liu","year":"2024","journal-title":"Front Microbiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-014-0029-7","article-title":"Current knowledge and future directions of TLR and NOD signaling in sepsis","volume":"2","author":"Foley","year":"2015","journal-title":"Mil Med Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1577105","article-title":"Sepsis-induced immunosuppression: mechanisms, biomarkers and immunotherapy","volume":"16","author":"Gao","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1763005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:12:04Z","timestamp":1774930324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1763005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2026.1763005"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1763005","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"article-number":"1763005"}}